Table 4: Comparison of demographic and clinical characteristics between mortality and non-mortality group.

Mortality Non-mortality value

Demographic characteristics
 Female10 (100%)15 (88.24%)0.387
 Age of onset AP (y) 0.123
 SLEDAI score at onset of AP 0.065
 Number of organs involved 0.167
 Intensive therapy of GC/ISA4 (40%)12 (70.59%)0.124

Clinical characteristics
 Fever10 (100%)11 (64.71%)0.042
 Mucocutaneous involvement6 (60%)12 (70.59%)0.439
 Articular involvement6 (60%)7 (41.18%)0.293
 Serositis7 (70%)8 (47.06%)0.226
 Neuropsychiatric involvement4 (40 %)3 (17.65%)0.204

Laboratory findings
 Serum amylase* 0.241
 Serum lipase* 0.368
 Elevated serum transaminase8 (80%)10 (58.82%)0.244
 Hypoalbuminemia9 (90%)8 (47.06%)0.031
 Proteinuria10 (100%)12 (70.59%)0.077
 Hematuria10 (100%)7 (41.18%)0.002
 Granular casts7 (70%)4 (23.53%)0.024
 Hyperbilirubinemia4 (40%)1 (5.88%)0.047
 Positive anti-dsDNA10 (100%)14 (82.35%)0.232
 Positive anti-Sm2/8 (25%)4/13 (30.77%)0.59
 Low C39/9 (100%)17/17 (100%)1.0
 Low C47/9 (77.78%)14/17 (82.35%)0.58
 Anti-Ro3/8 (37.5%)10/13 (76.92%)0.09
 Anti-La1/8 (12.5%)6/13 (46.15%)0.133

*Times in excess of the upper limit of normal (ULN).